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Foreword
BY BRUCE J. MARKOVITZ, MD

The Thomas Duane Ophthalmology Society (TDOS), founded at Jefferson
over 30 years ago, honors the great ophthalmologist Thomas David Duane,
MD, PhD. It provides a place for medical students with a mutual interest
in ophthalmology to meet, share educational events, and engage in
ophthalmology related community service. It has grown from my time as
President in 1987, when I had to roam the corridors of Alumni Hall begging
friends and strangers to come hear Dr. Jerry Shields speak after he graciously
agreed to address our group, into an extraordinarily successful organization
attracting 50 to 75 students to each event.
Over the years TDOS has always provided the opportunity for Jefferson
medical students to experience ophthalmology as a potential career
choice. Now, through inSIGHT, students have a creative outlet to explore
ophthalmology by interacting intimately with the great mentors at Wills
Eye and to then share their discoveries with others. We thank the worldrenowned staff at Wills Eye for sharing their personal reflections and
expertise with our students.
This second volume of inSIGHT once again offers up a wonderful selection of
articles taking the reader on a captivating tour of ophthalmic topics sampling
the diversity of ophthalmology. From the origins of the Wills Eye Manual
to cataract surgical techniques in third world countries reversing blindness
for millions to the cutting-edge technologies being used to restore and
preserve vision at Wills, you are bound to find something that interests you.
Whether you are a medical student, a resident, an ophthalmologist, or just a
curious lay person, I know you will enjoy the works of these creative student
writers as they share their stories with you. Given Dr. Duane’s passion for
education and literature, it is only fitting that his name be associated with
this second edition of the inSIGHT journal.

iv | inSIGHT

inSIGHT | Journal of the Thomas Duane Ophthalmology Society | Vol. 2 Issue 1

About
THE JOURNAL

inSIGHT is a student-run, non-peer reviewed journal established by
the Thomas Duane Ophthalmology Society to highlight the innovative
ophthalmic research, procedures, and faculty at Wills Eye Hospital and
Thomas Jefferson University. inSIGHT aims to promote student interest in
ophthalmology by supporting peer authors to report on diverse aspects
of the field, through editorial and opinion pieces. inSIGHT is proud to
present its second issue.
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A New Dimension to Offer
By Ari August, BS | Faculty Reviewer: Allen C. Ho, MD

T

echnological advancements are
crafted, fielded, and sold from
the vantage point of benefit: How
can this make my life better? The origins
of three-dimensional (3D) technology
are no different. 3D technology targets
the mind’s ability to make sense of
two different angles of an image, and
therefore perceive depth. Earlier models,
common in movie theaters and cereal
box toys, utilized red and blue lenses to
outwit one’s perception of a flat image
and project it into 3D images, promising
deeper immersive experiences and even
“x-ray vision.” More recently, the capacity
of 3D technology has expanded, as seen
with the recent virtual reality craze in the
entertainment field. The ability to use
software to create physical objects within
360-degree experiences allows users to

Figure 1. 2D digitized visualization
of an indocyanine green dye-assisted
macular peel from a standard operating
microscope.
10 | inSIGHT

not only observe a high-fidelity experience
but also actively manipulate projected
surroundings. Beyond the entertainment
industry, virtual reality has also been
utilized to improve educational outcomes1
through real-time 3D visualization of 3D
structures, showing great potential for
positive impact on student, physician, and
patient lives.
Within the field of ophthalmology,
the incorporation of 3D visualization
technology aims to improve on limitations
with current methods used to visualize
structures within the eye during surgery.
High-quality visualization of intraocular
structures is required for examination,
diagnosis, and surgery. According to
Wills Eye Hospital vitreoretinal (VR)
surgeon Dr. Allen C. Ho, visualization is
also “an unmet need” in retinal surgery.
The traditional method of visualizing
the eye during surgery is a Standard
Operating Microscope (SOM),2 which
provides bifocal 2D visuals using classical
optics. This microscope has a split ocular,
allowing for visualization of the surgical
field by two individuals simultaneously,
and can digitally project the surgical
field onto a screen for recording or
observation purposes. However, the
digital monitors of the projected images
are located away from the surgical field,3
putting students far from instruction,
narration, and the ability to ask questions.
Furthermore, this method of traditional
microscopic visualization comes with
“limitations in field of view, color, contrast
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and sharpness.”4 Compared to images
seen directly through SOM oculars, the
brightness, resolution, and colorization of
projected digital images (Figure 1) suffer.3
Overall, these limitations diminish the
potential for learning and visualization.5
In current 3D visualization systems for
ophthalmic surgery, two cameras attached
to an operating microscope will send
their signals to a central processor that
will transmit an image onto a monitor,
which can be viewed by surgeons wearing
polarized glasses so that they may
appreciate the 2D image in 3D (Figure
2). This technology lends to an immersive
experience in the operating room for all
those present (Figure 3).
3D visualization technology enhances
visibility with the real time use of computed
filters. Just as a digital photograph may
be artificially augmented to emphasize
contrast or warmer tones for the sake of
consumer experience, the application
of a filter allows for increases in image
saturation, especially of green tones,
which promotes better visualization of
stained regions (Figure 4).6 Furthermore,
the ability to adjust gain and brightness
on the end of the digitization rather than
a light source have led to an improved
ability to sufficiently highlight the retina
with an extra-globular light source used
as a scleral depressor.3 Finally, while
SOMs sacrifice some light to the dual
oculars for surgeon/observer viewing,
lowering the digital image’s quality, 3D
technology removes the use of oculars,
thereby decreasing the risk of light loss,3
which enhances the digital image (Figure
4). Thus, the benefits for visualization
with 3D digital augmentation can provide

unique benefits for both VR surgeons and
patients.
3D technology in VR surgeries not
only improves visualization but also
decreases risk for phototoxicity. Due to
its location and requisite viewing through
anterior ocular structures, visualization of
the posterior segment requires specific
posterior segment illumination, which may
increase risk for phototoxicity. The retina
is typically protected from phototoxicity

Figure 2. Dr. John Hinkle (retina fellow at
Mid Atlantic Retina) removes silicon oil via
vitrectomy using the NGenuity Alcon 3D
visualization system. The fellow is wearing
polarized glasses to appreciate the 2D
image transmitted through a central
processor onto a screen in 3D.
by pigments and antioxidants present in
the cornea, lens, uvea, and retina that act
to absorb wavelengths of electromagnetic
energy to prevent excitation and
damage.7 Upon exceeding a phototoxicity
threshold, the retinal epithelium, choroid,
and outer segments of the eye are at risk
of damage because of non-extensive
repair mechanisms, which may result in
permanent insult to retinal function.7 Such
phototoxic retinopathy may result from
thermal, mechanical, or photochemical
damage,8 including that which is caused
by SOM light.9 It has been found that
even with maximal precautions taken with
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light sources during SOM VR surgeries,
endoillumination can be unsafe with
respect to retinal phototoxicity.10 This is
especially of concern during vitrectomy
when light from a source does not pass
through the lens, and the threshold of
safety is surpassed with even just one
minute10 of exposure to most commercial
light sources. However, because of the
electronic processing functions of 3D
visualization, minimum endoillumination
during 3D VR surgeries was found to
be significantly lower compared to
SOM surgeries,2 lowering the risk of
phototoxicity.
VR surgeons also report greater
satisfaction with the use of 3D visualization
in surgery. Dr. Ho emphasizes the
advancement of this technology on
functional aspects of “magnification, focus,
depth of field, zoom, the ability to focus on
something in the macula but also see its
effects on the periphery.”5 VR surgeons are
also able to overlay ocular computerized
tomography intraoperatively to promote
surgical decision making.11 Additionally,
3D technology has been found to provide
ergonomic benefit compared to SOM
surgical methods.2,3,12 The wide-angle
stereoscopic view of 3D visualization as
well as additional freedom of movement
and positioning with use of 3D glasses
(Figure 2) provides an added benefit of
“freeing the surgeon from the physical
confines of [SOM] eyepieces”2 so they can
operate with proper ergonomics. This is
especially of importance to VR surgeons,
who have high rates of spinal pain,
possibly due to the frequent adoption of
poor body mechanics.13
As with any new advancement in a
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field, enthusiasm for 3D visualization
technology is not universal. There is no
surprise that shiny new technology comes
with a shiny new price tag, but surprisingly,
there is a lack of discourse surrounding
cost-effective evaluation of 3D surgery. A
lack of use, however, is evident. Only half
of the training institutions with access to
an NGenuity Alcon 3D surgical system,
the current 3D technology system used
by VR surgeons, have ever used it!14
This discouraged use may be due to the
observation of a lag between a user’s
actions and the feedback shown on the
screen. However, one study found the
latency of the system to be 70ms, which
was detectable by 0% of users during
internal limiting membrane peeling and
4% of users during external suturing.14
For both actions, there were no clinical
implications of the 70ms lag.4,14 The lack
of use may also be due to a perceived
learning curve, which is often thought to
be much more difficult to adapt to than
research suggests. Some studies report
proficiency after one day’s cases.15 Dr.
Ho also expresses, “I think people will
become adept and adapt very quickly,
faster than they think they will.”5 He adds
that fellows under his teaching adapt to
the technology after just a couple of cases
with it.5
Despite some hesitancy, the future of
3D VR surgery still provokes enthusiasm for
what may come. VR surgeons who utilize 3D
visualization technology openly encourage
its expansion, even creating best practice
tips and guides to help facilitate an easier
transition and more rapid learning curve.15
Some individuals are excited by findings of
improved vitrectomy16 or the potential of
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Figure 3. Dr. Allen C. Ho performing retinal
surgery using the NGenuity Alcon 3D
visualization system.
more safe and efficient procedures,11 and
others are hopeful that 3D VR surgery may
be a gateway to “telesurgery”17 in which
a surgeon can operate, via joystick, from
anywhere in the world. And even in the
shadow of science fiction in near reach,
some individuals might just be holding
onto the possibility of 3D observation
experiences helping them perform better
on anatomy examinations.18 Regardless,
the future of 3D VR surgeries are sure to
remain in sight.
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Neuro-Ophthalmology Subspecialty Highlight:
With Dr. Sarah Thornton, Wills Eye Hospital
By Joseph D. DeSimone, BS | Faculty Mentor: Sarah Thornton, MD
Introduction
euro-Ophthalmology
is
a
subspecialty within ophthalmology
that combines the complexities
of nervous system disease with the
intricacies of the ocular manifestations of
those diseases. Neuro-ophthalmologists
work
closely
with
neurologists,
neurosurgeons, rheumatologists, and
other ophthalmologists in different
subspecialties, such as retina and
glaucoma, to get to the source of their
patients’ problems. Neuro-ophthalmology
is typically a 1-year fellowship undertaken
after residency training is completed,
where physicians will learn the complex
ways different diseases can manifest in the

N

eye.
A typical day in the NeuroOphthalmology clinic varies, but usually
involves managing patients with various
diseases such as Myasthenia Gravis,
Multiple Sclerosis, Optic Neuritis, Giant
Cell Arteritis, Thyroid Eye Disease, and
many others. A thorough history is essential
for diagnosing these patients, as subtle
details can give hints into the etiology
of a patient’s disease. Some common
symptoms of neurologic disease include
diplopia, sudden or transient vision loss,
blurry vision, ptosis, headaches, or cranial
neuropathies. A rigorous physical exam
requires measuring visual acuity, visual
fields, eye pressure, proptosis, extra-ocular

Dr. Sarah Thornton is an attending in the Neuro-Ophthalmology service at Wills
Eye Hospital. She attended Sidney Kimmel Medical College, where she decided to
pursue ophthalmology after rotating through the Wills Emergency Room as a thirdyear student: “I found the pathology so fascinating and the patients so grateful for
an explanation and treatment of their eye condition. I also wanted to learn how to
use this mysterious slit lamp device, which provided a direct view of the pathology
in real time.” After graduating from SKMC, Dr. Thornton pursued a residency in
ophthalmology at Tufts Medical Center. She recalls being exposed to the “bread-andbutter” of ophthalmology, as well as interesting subspecialty clinics and time in the
operating room. She enjoyed living in Boston, and discussed that Tufts has a dynamic
balance of faculty supervision and autonomy that fostered her independent learning.
A word of advice from Dr. Thornton: “When choosing a residency, I think it’s helpful to
think about your own values and prioritize the most important things for you, whether
that be location, surgical volume, etc., and try to find a good fit.” After graduating
residency, she returned to Philadelphia for a Neuro-Ophthalmology fellowship under
the guidance of Drs. Robert Sergott, Mark Moster, and Adam Debusk. She chose to
pursue Neuro-Ophthalmology because she “always found those cases most interesting
during residency and appreciated the analytical reasoning required to diagnose these
challenging cases”, and she “continues to be amazed by the diversity of pathology in
the field.” (Figure 1).
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“When choosing a
residency, I think it’s
helpful to think about
your own values and
prioritize the most
important things for
you.”
Dr. Sarah Thornton
Figure 1
muscle ranges of motion, color vision, pupil
responses to light and accommodation, as
well as performing a slit lamp examination
or using direct or indirect ophthalmoscopy.
Diagnostic testing can involve a variety of
imaging and lab tests depending on the
patient. Imaging typically includes optical
coherence tomography (OCT), visual
field testing, computed tomographic
(CT) or magnetic resonance imaging
(MRI) scanning of the brain and orbits,
and sometimes fluorescein angiography,
electroretinography, and ocular ultrasound.
Lab orders can also aid in diagnosing
specific diseases, and some common tests
used by neuro-ophthalmologists include
inflammatory markers C-reactive protein
(CRP) and erythrocyte sedimentation
rate (ESR), disease-specific antibodies
in the serum, or genetic testing for rare
hereditary diseases affecting vision, such
as Leber’s Hereditary Optic Neuropathy.
Clinical Pearls
Dr. Thornton shared some clinical pearls
that medical students can use in clinical
rotations in neurology and ophthalmology

and beyond in clinical practice.
1. Pupillary Light Reflex: The pupillary
response to light is a complex process
but can give you great detail when
evaluating a challenging neurological
patient. Physicians test to see if the pupils
are responding to light appropriately,
and if the pupils appear symmetric or
asymmetric. Normally, when light is
shone into one eye, the retina will send
a signal via the optic nerve (cranial
nerve II) to both pretectal nuclei in the
midbrain, which activate bilateral EdingerWestphal nuclei, sending signals via both
oculomotor nerves (cranial nerve III) to
the sphincter pupillae muscles, resulting
in bilateral pupillary constriction. If there
is an asymmetric issue along the pathway,
you will see a relative afferent pupillary
defect, or RAPD, which occurs when the
eyes dilate in response to light. RAPDs
can be seen in a variety of diseases and
lesions along the pathway to the brain,
and some common etiologies include
optic neuritis, ischemic optic neuropathy
or compressive optic neuropathy, although
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RAPD can sometimes be seen with severe
asymmetric retinal disease.
The Swinging Flashlight test is used to
look for a RAPD. To perform this test, the
examiner will shine light into one eye to
attain maximum constriction, then quickly
switch the light source to the other eye
and back again. Normally, the second eye
should respond with the same pupillary
constriction as the first eye as a result of
the consensual response. If the eye does
not respond at all to the light source and
remains dilated, then there should be
concern for optic nerve damage. Light
shone in the unaffected eye will cause both
eyes to constrict. Conversely, light shone
in the affected eye will cause both eyes
to dilate (Figure 2).1 This is also termed a
Marcus Gunn Pupil.

Figure 2
2. Bell’s Palsy Examination: Bell’s palsy is
idiopathic inflammation and dysfunction
of the peripheral facial nerve (cranial
nerve VII) that results in facial weakness
or paralysis that typically affects one side
of the face.2 Patients with Bell’s Palsy will
have unilateral facial drooping, drooling,
difficulty closing the eye on the affected
side, and difficulty smiling. Bell’s palsy can
limit the ability to blink, which can lead
to painful corneal irritation and dryness
16 | inSIGHT

leading to damage and vision problems.
Evaluation of Bell’s Palsy involves asking
the patient to perform the following
movements to test cranial nerve VII
function and to differentiate an upper and
lower facial nerve lesion:
• “raise your eyebrows” → affected side
will not show forehead wrinkling and
brow furrowing
• “smile” → affected side will have a flat
facial contour
• “puff out your cheeks” → affected
side will not be able to expand relative
to the unaffected side
• “forcefully close your eyes” → affected
side will not be able to fully close their
eyes due to weakness of the frontalis
muscle
• “stick out your tongue” → to check
for lesions to the hypoglossal nerve
(cranial nerve XII), will deviate toward
affected side of nerve injury
• stroke forehead, upper face, and lower
face bilaterally → to check for lesions
to the ophthalmic (V1), maxillary
(V2), and mandibular (V3) divisions
of trigeminal nerve (cranial nerve V)
sensations, respectively
Clinical Challenge
A 28-year-old woman with a past
medical history of obesity, type 2 diabetes
mellitus, obstructive sleep apnea, and
migraines since childhood presented
to the Wills Eye Hospital Emergency
Department with one month of positional
headaches, transient visual obscurations,
and blurry vision in her right eye (OD). The
best corrected visual acuity was 20/200
OD and 20/60 in her left eye (OS) with a 2+
APD OD. She had full color plates but was
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slower OD. Fundoscopic exam revealed
bilateral disc edema. Magnetic resonance
imaging of the brain and orbits revealed
slight protrusion of both optic nerves
and a partially empty sella. MRV showed
short segment stenoses at the bilateral
transverse sigmoid sinuses. She was unable
to undergo bedside lumbar puncture (LP)
and was admitted for IV acetazolamide
(Diamox) and a fluoroscopy-guided LP.
The LP had an opening pressure of 46
cm H2O. Results of cerebral spinal fluid
analysis and serology tests were negative

(shown below, Figure 3). OCT showed
severe bilateral disc edema, OD worse
than OS. There was retinal nerve fiber layer
(RNFL) edema extending into the fovea
with exudates, chorioretinal folds, and
peripapillary hemorrhages OD. Left eye
showed RNFL edema with early tracking
not extending beyond the prepapillary
region, Paton’s lines, and peripapillary
hemorrhages. Inferior nerve thickness was
445 μm OD and 426 μm OS.
What is the next best step in the
management of this patient?
A. continue Diamox and suggest weight
loss
B. prescribe Dorzolamide-Timolol eye
drops
C. consult Neurosurgery for placement of
a ventriculoperitoneal shunt
D. consult Glaucoma for tube shunt
placement
Answer: C

Figure 3
for infectious and inflammatory etiologies,
including syphilis, sarcoidosis, Lyme
disease, and tuberculosis. Serum studies
revealed sickle cell trait and a hemoglobin
A1c of 6.8%. She was discharged and was
to continue Diamox 1 gram three times
per day.
One week later in the Neuroophthalmology clinic, she underwent OCT

Discussion
The
differential
diagnosis
for
papilledema
includes
idiopathic
intracranial hypertension, intracranial mass,
obstructive hydrocephalus, meningitis, or
cerebral venous sinus thrombosis.3 This
patient was diagnosed with pseudotumor
cerebri (PTC), also known as idiopathic
intracranial hypertension, a syndrome
consisting of increased intracranial
pressure, headaches, and visual loss not
attributable to a mass lesion or underlying
infection or malignancy.4 PTC is normally a
more insidious condition, allowing time to
May 2022 | 17

treat medically and with weight loss. More
rarely, PTC has a fulminant presentation,
and consideration for surgical intervention
is warranted. This patient’s intracranial
pressure was not responding appropriately
to medical therapy with acetazolamide
alone, so surgical intervention was
recommended (eliminating choice A). This
patient has increased intracranial pressure,
so methods to lower intraocular pressure
would be ineffective in treating PTC
(choices B and D). The patient was referred
to Neurosurgery for ventriculoperitoneal
(VP) shunt placement (choice C). When
considering surgery for PTC, options
include optic nerve sheath fenestration,
VP shunting, or venous sinus stenting.
The overall rate of visual improvement
seems to be equivalent across surgical
interventions, and there is insufficient
evidence to recommend or reject any one
surgical intervention over another at this

Figure 4
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time.5,6
Two months after shunt placement, the
patient was evaluated again by NeuroOphthalmology. Visual acuity was 20/40
OD and 20/20 OS and color plates were
full in both eyes. OCT showed significant
improvement
in
papilledema,
now
measurable with inferior thickness 124 μm
OD and 109 μm OS (Figure 4).
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A Day in the Life in the Wills ER
By Samara Hamou, MS1 | Faculty Reviewer: Christine Chung, MD

Entry to the emergency room; located on
the first floor of the Jefferson Hospital for
Neuroscience.

T

he Wills Eye Hospital — among
the greatest eye hospitals in
the country — is a force to be
reckoned with. Located in Center City
Philadelphia, the eight-story tall brick
facility will capture your attention as you
stroll down Walnut Street. The entrance
to the Wills Eye Emergency Room (ER),
however, is less apparent to the average
city-goer. Located directly across from the
Hospital, the red and blue entrance sign
may go unnoticed to the unsuspecting by
passer. However, for those who require
expert eye care in a timely fashion, the
Eye Emergency Room is a signal for
the invaluable services provided by the
doctors and trainees inside.
The Wills Eye ER is one of only three
emergency rooms in the country dedicated
exclusively to emergency eye care. It is
available 24 hours a day, 365 days a year,
and serves over 1600 patients each month.
The hospital’s world-renowned reputation
uniquely attracts patients throughout the
Eastern Seaboard who seek access to the
world-class expertise and emergent eye
care available at Wills.

As a first-year medical student at
SKMC, I was fortunate to catch a glimpse
of what goes on behind the scenes during
a typical day in the Wills ER. There are five
exam rooms and one triage room. Acute
eye emergencies account for about 60%
of the visits, with the rest comprising of
non-emergent visits. Patients come in on
their own volition, or are referred from
local urgent care, primary care services,
their ophthalmologist or ER’s as far away
as Lehigh Valley. All patients are triaged
by a registered nurse upon presentation,
a process that starts with visual acuity
and vital signs. On my particular visit, the
attending physician, Dr. Christine A. Chung,
then performed a pupil exam to clear the
patient for dilation in preparation for a full
eye exam. If cleared, a first- or secondyear ophthalmology resident will gather
a history and conduct a full ocular exam
consisting of color testing, confrontational
visual field testing, motility, applanation
tonometry, slit lamp, and dilated fundus
exam. The patient is then seen a second
time by the attending ophthalmologist for
final review. After completing the patient
work up, the resident and attending team
discuss the findings, and together create a
diagnostic assessment and treatment plan.
Depending on the diagnosis and nature of
the case, the patient is either discharged,
sent for further imaging, or admitted.
I was amazed at the myriad of patients
I witnessed throughout the several hours I
spent observing in the Wills ER. Encounters
ranged from something as straight- forward
as a superficial foreign body requiring
removal and treatment with topical drops,
to complex ocular pathology such as
cavernous sinus hemangioma requiring an
intense work-up and further testing. I
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field performed by the ophthalmology
resident on initial evaluation revealed a
right upper quadrant homogenous field
defect. The slit lamp exam and fundus
exam were unrevealing, and the patient
was scheduled for a brain MRI to confirm
the working diagnosis of a subacute
stroke. Unfortunately, an MRI workup
takes several hours to complete, and the
nature of the emergency room does not
always allow you to follow a patient to
completion.

A typical exam room in the Wills Eye ER.
distinctly recall three patients that came
through which left quite an impression on
me.
Case 1: A 70-year-old man presented after
falling the prior day while carrying bags of
gardening soil. Since he was holding the
bags of soil, he was unable to stop his fall
and fell directly on his face. Upon arrival,
his blood pressure (BP) was elevated to
200/120. He reported good BP control on
his home anti-hypertensive medications,
but admitted to forgetting his regular dose
that morning. Ocular examination quickly
revealed that he had a full thickness corneal
laceration requiring urgent repair (Figure
1). After starting IV antibiotics, the Wills
ER was able to admit him to the Jefferson
Hospital for Neuroscience for stabilization
of his BP prior to surgery. The patient was
then scheduled for open-globe repair at
Wills Eye the following day.
Case 2: A 75-year-old man recovering
from COVID-19, diagnosed three weeks
earlier, presented with debilitating
headaches, elevated BP and tunnel vision.
These symptoms led the patient to see
an optometrist, who found a “poor visual
field” and promptly referred him to the
Wills Eye ER. A confrontational visual
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Case 3: A 54-year-old man with a history
of recent shingles presented with a chief
complaint of double vision (diplopia) for
the past month. His medical history was
significant for uncontrolled diabetes,
well-controlled
hypertension,
and
hypercholesterolemia.
A Three-Step
Test was performed (Figure 2), and the
etiology of his diplopia was determined to
likely be a unilateral cranial nerve IV palsy.
The residents presumed that this palsy
could be due to microvascular ischemia
from uncontrolled diabetes or from his
recent shingles infection. He was sent
for an MRI which showed no intracranial
mass, hemorrhage, or acute infarct, and
was consistent with microangiopathy. The
patient was advised to follow up

Figure 1. Anterior ruptured globe enhanced
with yellow fluorescein dye, subconjunctival
hemorrhage, and surrounding ecchymoses.
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with a neuro-ophthalmologist for his
diplopia, and with a comprehensive
ophthalmologist to monitor the incidental
diabetic retinopathy found on dilated
fundus exam.
It became evident to me that the Wills
Eye residents are essential for running the
ER. The residency program itself is one of
the most competitive and largest in the
country, and accepts a total of 8 residents
each year. Residents complete various
6-week rotations in comprehensive and
subspecialty clinics, the emergency
room, consult service at Jefferson, and
the operating room at Wills Eye Hospital.
An ophthalmology attending supervises
the residents during the week, and an ER
attending covers overnight and during the
weekend. I had the privilege of working
with Dr. Kaylene Carter (PGY-2) who shared
that the most rewarding part of her Wills
Eye experience so far has been working
with amazing co-residents from around
the country. When asked about the most
challenging part of residency so far, she
reflected upon the “steep learning curve
with a high volume of patients in the ER
that definitely takes some adjusting to.”
Across the many patient encounters
that day, I was able to appreciate how
ocular symptoms can serve as presenting
signs of systemic diseases that often
involve multiple organ systems, especially
the brain. I witnessed first-hand the
meaning behind the cliché expression
“the eye is the window to the soul”, which
could not be more evident throughout the
various diagnoses made during my time
shadowing Dr. Chung and the talented
Wills Eye residents.

Figure 2. Dr. Bonnie Sklar (PGY-3) using
various sets of prisms to quantify diplopia
severity after performing the Parks ThreeStep Test, a diagnostic test used to identify
which muscle is paretic in the case of an
acquired hypertropia.
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Origins of the Wills Eye Manual:
Surviving the Test of Time
By Jordan Safran, BS | Faculty Mentor: Christopher Rapuano, MD

T

he first copy of the Wills Eye Manual
hit the press in late 1989; it featured a
black cover page with bold gold lettering
and the Wills Eye logo proudly displayed
on top. Published in a time before the
invention of the world wide web or the
advent of digital printing, this 450-page
expertly sourced ocular disease reference
guide took the ophthalmology world by
storm. Since its debut, the manual has
served as the go-to guide for trainees and
seasoned physicians alike in diagnosing and
treating more than 200 ocular diseases. To
date, the Wills Eye Manual has published
eight editions, with over 200,000 copies in
circulation within ophthalmology clinics,
emergency departments, and hospitals
around the world.
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Humble Beginnings
Considering how impactful the Wills Eye
Manual is today, it is remarkable that
this cornerstone publication started as a
small project for two ambitious Wills Eye
ophthalmology residents. Dr. Christopher
Rapuano, Chief of the Cornea Service at
Wills Eye and one of the two founding
editors of the Wills Eye Manual, explains
that the story of the Wills Eye Manual
began in June of 1988 at the tail-end of
his first year of residency. At the time,
ophthalmology trainees spent their first
year learning the ins and outs of the field
by interviewing and examining patients
with guidance from second-year residents.
Dr. Rapuano shared how this pivotal point
in his education contributed to the early
beginnings of the Wills Eye Manual: “I
realized that I would soon become a
mentor to the first years and wanted to be
prepared for the role. I started to work on
a framework to organize my knowledge
with a simple goal in mind, to create
a rudimentary guide to the top 10-20
diagnoses encountered in the Wills Eye
ophthalmology emergency department.”
Shortly thereafter, this undertaking led
Dr. Rapuano to his classmate, Dr. Mark
Friedberg, who shared a passion for making
ophthalmology knowledge accessible.
Discussions between them centered
around two ideas: creating a booklet for
ophthalmology residents in the Wills Eye
ER and drafting a book about conditions
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of the eye for non-ophthalmologists. Over
the next few weeks, the synergy of these
ideas culminated into a four-chapter-long
sampler of an eye disease diagnosis and
treatment guide bound for the desks of
several major publishing companies.
Founding Principles
Dr. Rapuano described the vivid memory
of his first encounter with a publishing
company. He and Dr. Friedberg, donned
in their white coats, entered an office
sporting ornate wooden architecture and
bookshelves lined with countless medical
texts. As they took their seats, they were
joined by about ten senior editors and
publishers at Lea & Febiger to discuss
the fate of their brainchild. For most this
would be a daunting scenario, but Dr.
Rapuano and Dr. Friedberg had come

prepared with an elegant proposition.
“We presented our vision for the manual
to the publishers” remarked Dr. Rapuano,
“to create a guide that would give
ophthalmologists information right at
their fingertips – no pathophysiology,
histology, or surgery, just the essentials
to treat a patient with ocular disease. It
would be soft cover, small enough to fit
into a lab coat pocket and affordable.”
This manual would be completed with the
assistance of their entire residency class
and reviewed by Wills Eye attendings.
Further, they had arranged that future
Wills Eye resident classes would be the
successors for revising and publishing
new editions of the manual. This proposal
was pitched to three more publishers in
Philadelphia’s Washington Square area –
the epicenter for medical publication at
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the time. Astonishingly, all four companies
were enthralled with this revolutionary
idea and offered them contracts; the tobe ophthalmologists ultimately signed a
deal with J. B. Lippincott Company and
the writing began.
Writing the Wills Eye Manual
Over the subsequent nine months, the
Wills Eye residents worked together on
the first edition of the manual. Dr. Rapuano
and Dr. Friedberg served as editors and
assigned sections to each of the residents
in their class. Residents refined their
additions to the manual by consulting
with attendings at Wills Eye. Dr. Rapuano
recalled these meetings fondly: “one-onone discussions with some of the world’s
leading experts for the manual enriched
our understanding of ophthalmology
and was the most rewarding part of the
project.” The Wills Eye Manual would
provide everything from pearls in ocular
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oncology directly from Drs. Carol and
Jerry Shields to the newest developments
in glaucoma from Dr. George Spaeth. The
team worked diligently to summarize the
essentials, sometimes opting to include
multiple perspectives in the management
of certain conditions to account for
discrepant expert opinions. While the
original plan was to include 100 diagnoses,
the final product morphed into a reference
guide of over 200 conditions. The manual
was submitted for publication by April and
Drs. Rapuano and Friedberg were told
that it was the fastest book authors had
delivered to Lippincott in its history. The
residents had worked tirelessly to bring
their idea to fruition; however, there was
still uncertainty whether the project would
catch on. Impressively, the first edition
sold 15,000 copies, about triple what the
publishing company had hoped for.
Surviving the Test of Time
When the Wills Eye Manual was
published, it was the first of its kind. While
ophthalmology atlases and textbooks
existed, this was the first reference
guide that allowed for any physician to
rapidly access reliable, practical, up-todate information to recognize and treat
a vast array of eye conditions. This was
particularly groundbreaking in a time when
there were no search engines or internet
medical databases. Despite developments
over the past 30 years such as EyeWiki and
UpToDate, the Wills Eye Manual holds its
ground as one of the best-selling books
in ophthalmology. The manual’s continued
popularity in the age of unprecedented
information access may be credited to the
preservation of its founding principles.
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According to Dr. Rapuano, “when the
contract was created for the manual, it was
decided that all funds raised from sales
would be directed towards the Wills Eye
Residency program.” This has encouraged
continued support from residents and
faculty, allowing for the manual to adapt
with the times without compromising its
beloved simplicity and authoritative voice.
Over the years, the manual incorporated
color photos, and more recently has added
online accessibility and video addendums.
Sections within the guide have also been
added to reflect the newest developments
in ophthalmology such as imaging
modalities.
Regarding the progress of the manual,
Dr. Rapuano shares, “I am proud of the
hard work residents have dedicated
over the years to uphold the tradition
of the Wills Eye Manual.” Dr. Rapuano
has remained an integral part of the
manual’s success over the years acting
as the primary faculty supervisor for all
subsequent editions and has continued
to advance the field of ophthalmology.
Since completing his cornea fellowship at
the University of Iowa, his contributions
to the field of ophthalmology have
been numerous as one of the world’s
leading experts in corneal disease,
refractive surgery, and excimer laser
phototherapeutic keratectomy surgery.
In addition to the Wills Eye Manual, he
has authored numerous works including a
cornea textbook, being the series editor
for the Wills Eye Color Atlas Series and
over 250 peer-reviewed articles. His
vision for the future of the manual is to
continue including the most cutting-edge
information, while never compromising

on the philosophy of practicality that
lives at its core. The Wills Eye Manual
will continue to be the north star for
physicians navigating the complexities of
ocular diagnosis and treatment, even as
new discoveries abound.
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GATT: A Micro-invasive Glaucoma Surgery
and a Big Step for Glaucoma Treatment
By Moses Im, BS | Faculty Mentor: Lauren Hock, MD & Marlene Moster, MD

G

laucoma is a group of ocular
diseases characterized by damage
to the optic nerve that may lead
to permanent vision loss. Currently, 76
million people (aged 40-80 years) suffer
from glaucoma, and the prevalence is
projected to increase to 111.8 million by
2040.1 The diagnosis of glaucoma can be
frightening, particularly because there
is no known cure. Fortunately, recent
advancements in glaucoma surgery have
made more options available for patients
presenting with new-onset glaucoma. In
particular, patients with mild to moderate
glaucoma may be eligible for newer
minimally invasive glaucoma surgeries
(MIGS). This review is both an overview of
MIGS, a new class of glaucoma surgeries,
and a case study on how one of these
novel procedures saved a 47-year-old
woman’s vision.
Glaucoma is an optic neuropathy
characterized by progressive deterioration
of the retinal neural ganglion and nerve
fiber layer.2 The exact mechanism of nerve
damage is unknown, but high intraocular
pressure (IOP) is commonly correlated.
Under normal conditions, IOP is maintained
through a constant flux of aqueous fluid
from the posterior chamber through the
pupil into the anterior chamber of the
eye.3 The aqueous humor nourishes the
anterior chamber and then leaves via the
trabecular meshwork and Schlemm’s canal
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into the venous drainage system deep
within the sclera. In open-angle glaucoma,
elevated IOP may be due to progressive
microscopic clogging of the trabecular
meshwork, the primary source of aqueous
outflow (Figure 1).3 Secondary openangle glaucoma can commonly occur
with chronic corticosteroid use, where
there is a similar microscopic clogging
of the trabecular meshwork. The exact
process of aqueous outflow impediment
is uncertain, but it is hypothesized that

Figure 1. Anatomy of the eye demonstrating
the aqueous fluid movement from the
anterior chamber into Schlemm’s canal
through the trabecular meshwork. Blockage
of the trabecular meshwork seen in primary
open-angle glaucoma. Figure adapted from
National Eye Institute, National Institutes of
Health Media Library.13
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glycosaminoglycan accumulation in the
trabecular meshwork causes elevated
IOP.4 Early-onset of glaucoma is typically
asymptomatic, but glaucoma progression
leads to characteristic visual field loss.
The treatment options for glaucoma
include medications, laser, and surgical
intervention. Importantly, these treatments
help prevent disease progression but do
not reverse visual field loss. Therefore, early
treatment is critical for the maintenance of
vision and maximizing quality of life.5
Of the surgical interventions, the most
performed traditional procedure is a
trabeculectomy. This procedure lowers the
IOP by creating an alternative drainage
pathway, or a “bleb”, for the aqueous
fluid. A small incision is made through
the superior limbus, the border between

bleb leaks, and infections like blebitis
and endophthalmitis.5-7 Importantly, these
complications may result in blindness.
While trabeculectomy is often indicated
for patients with severe glaucoma, its risks
are often considered too great to treat mild
to moderate disease. As a result, novel
surgery alternatives have been explored
in the past decade to treat patients with
mild to moderate glaucoma.
In the past few decades, MIGS (Minimally
Invasive Glaucoma Surgery) has emerged
as a novel class of surgery to reduce IOP
with the aim of creating minimal damage
to the sclera or conjunctiva, reducing
the duration of recovery, and producing
more standardized outcomes.5 Several
forms of MIGS increase aqueous outflow
by bypassing the trabecular meshwork,

Figure 2. Intraoperative and Postoperative Images of Trabeculectomy A) Anatomy of
the eye demonstrating the new opening made in trabeculectomy. B) Real image of the
incision through the superior limbus. C) The arrow indicates the bleb that forms from
the elevation of the conjunctiva. Image A adapted from National Eye Institute, National
Institutes of Health Media Library. Images B and C provided by Marlene Moster, MD,
Wills Eye Hospital.

the cornea and the sclera, so that excess
fluid drains under the conjunctiva (Figure
2). While trabeculectomy is effective, it
requires a lengthy 6-week recovery period.
Serious risks include hypotony (very low
IOP), choroidal effusion, hemorrhage,

whereas other forms reduce fluid
production by ablating the ciliary body.
A common technique used in MIGS is the
“ab interno” approach. In this technique,
a corneal or limbal microincision is
performed to preserve ocular tissue rather
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than the classic scleral incision used in
trabeculectomy. The iStent is a MIGS
procedure, where a 1mm stent is inserted
through the trabecular meshwork into
Schlemm’s Canal, allowing for increased
outflow of aqueous fluid.8 The Kahook
dual blade is another MIGS device that
is inserted into Schlemm’s Canal through
the trabecular meshwork. The ramp of
the blade subsequently excises a strip
of the trabecular meshwork, exposing a
direct opening to the outer wall of the
Schlemm’s Canal.9 Another MIGS stent is
XEN, a gel stent that is inserted from the
anterior chamber to the subconjunctival
space, creating a small outflow tunnel that
functions similarly to the bleb formed with
a trabeculectomy.10 While many studies
show that standard glaucoma surgeries
reduce IOP to a greater degree than MIGS,
MIGS has demonstrated good efficacy in
decreasing IOP in select mild to moderate
cases while also displaying reduced rates
of complications.8,9,10
The gonioscopy-assisted transluminal
trabeculotomy (GATT), another MIGS
subtype, was first introduced by Grover
et al., from Glaucoma Associates of Texas.
GATT is a MIGS procedure that involves
threading a catheter or suture through
Schlemm’s canal within the anterior
chamber in a 360-degree manner. The
distal tip of the catheter or suture is then
removed, causing a circumferential tearing
of the roof of Schlemm’s canal (Figure
3).11 Grover, et. al. described GATT as a
safe and effective procedure in 2014. The
authors divided 85 patients into primary
open-angle glaucoma and secondary
glaucoma cohorts. In the primary glaucoma
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group, there was a 30% ± 22.7% mean
reduction in IOP, while in the secondary
glaucoma group, there was a 52.7% ±
15.8% reduction. The most common
complication was transient hyphema,
occurring in 30% of patients within 1 week
of surgery. Finally, there was a 9% failure
rate, where 8 patients required additional
glaucoma surgery. The GATT procedure
was further analyzed by Rahmatnejad
and Moster et al. at Wills Eye Hospital in
2017.12 In their retrospective chart review
of 66 patients, they had a 63% success
rate, where surgical success was defined
as not needing further glaucoma surgery
upon follow-up evaluation. They reported
a 44% mean reduction in IOP and a
38% rate of hyphema at postoperative
week one, which decreased to 6% at
one month. Their results suggested that
GATT was effective and had lower rates
of serious complications. Furthermore,
this operation requires no sutures and
preserves conjunctival tissue by avoiding
the creation of a bleb, allowing for future
glaucoma surgeries if needed. In summary,
GATT is a promising procedure with a
lower risk of serious complications for the
future of glaucoma surgery.
To highlight the promise of MIGS, we
will describe the case of a 47-year-old
Jefferson Internist whose vision was
preserved through the GATT operation.
This healthy physician, with no family
history of uveitis, glaucoma, or blindness,
developed abrupt uveitis in both eyes
and an epiretinal membrane in her left
eye. She was prescribed topical and
oral steroids for months to control the
uveitis and developed steroid-induced
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glaucoma. After which, she was prescribed
oral
Diamox
(acetazolamide),
for
maximum IOP control. However, when she
presented to Dr. Marlene Moster, her IOP
remained elevated (OD 48 mmHg, OS 50
mmHg; normal 10-21 mmHg). Her vision
was 20/20 in the right eye and 20/40 in
the left eye. On exam, she was noted to
have mild bilateral posterior subcapsular
cataracts, with more advanced cataracts
in the right eye. She had a disc damage
likelihood score (DDLS) of 3/10 bilaterally
which indicated mild optic nerve damage
without visual field loss. The optical
coherence tomography (OCT) displayed
the preservation of nerve fibers (over 100
microns).
While this patient presented with steroid
induced elevated IOP, she did not yet
have significant optic nerve damage and
as a result, was a good candidate for the

GATT procedure. GATT was performed
on her left eye followed by the right eye.
Since surgery, the patient demonstrates
stable IOPs (11mmHg) and only takes one
drop of aqueous suppressant daily. At her
5-year follow-up, the uveitis is controlled,
her visual fields and OCT were normal, her
optic nerve appearance was unchanged,
and her vision was 20/20 bilaterally. This
case demonstrates how a busy physician
was able to maintain her vision and
excellent quality of life. GATT surgery
can oftentimes be an effective treatment
option for patients with mild to moderate
glaucoma, particularly in steroid-induced
glaucoma.
In summary, while traditional glaucoma
surgeries, such as trabeculectomy, are
effective at lowering IOP, the rise of MIGS
operations provides safer options for
patients meeting certain criteria. Further

Figure 3. Demonstration of the steps of the GATT procedure. A) Initial corneal incision is
made. B) The catheter is inserted into the anterior chamber. C) An incision in the trabecular
meshwork is made to gain access to Schlemm’s canal. D) The distal tip of the catheter
canulates Schlemm’s Canal. E) The catheter is passed through the canal in a 360-degree
manner. F) The distal tip of the catheter is retrieved and removed to create the circumferential
tear of Schlemm’s Canal. Images provided by Marlene Moster, MD, Wills Eye Hospital.
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research is needed to identify the best
candidates for GATT, while also clarifying
the long-term efficacy of this operation.
Overall, MIGS, particularly GATT, is an
exciting and promising development for
the field of glaucoma.
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Manual Small-Incision Cataract Surgery
By Ankur Nahar BS | Mentor: Brenton D. Finklea MD

O

f the 49 million people living
with blindness worldwide, 15.2
million are blind due to cataracts,
making it the leading cause of preventable
blindness.1,2 Furthermore, 65.2 million
people experience moderate to severe
vision impairment from cataracts, according
to the World Report on Vision published
by the World Health Organization (WHO).3
While global cataract surgery efforts have
been a major success over the past three
decades, an aging population has resulted
in a rapid rise in cataracts, primarily in lowand middle-income countries (LMICs).2,4
To address the increasing demand for
cataract treatment, countries must perform
an equal or greater amount of surgeries
than the incidence of cataracts.
LMICs experience a unique set of obstacles
to overcome in addressing the cataract
surgical need. Methods of cataract surgery
via phacoemulsification, as performed
in affluent countries, are not suitable
due to the unfavorable cost, speed, and
availability of this surgical technique.
Manual small-incision cataract surgery
(MSICS) has, therefore, become the goldstandard in LMICs as a result of its low cost,
short case time, and excellent outcomes
when compared to phacoemulsification.5
Modern MSICS is a technique that cannot
be attributed to a single individual but
rather has been developed over the past
three decades by a cohort of highly skilled

surgeons. One of the first major steps
towards modern MSICS was described by
Dr. Michael Blumenthal and colleagues in
1992 as a modification to extracapsular
cataract extraction (ECCE), where the
entire natural lens is removed through a
large limbal incision in the eye.6 MSICS
using the Blumenthal technique requires
a 5-7 mm superior scleral incision to
extract the cataractous lens. The sclerocorneal tunnel architecture was designed
such that when the eye is pressurized,
the wound is watertight and requires no
sutures for closure. The technique was
further modified by Dr. Sanduk Ruit and
colleagues in 1999, whose surgical steps
have formed the backbone of most current
MSICS styles.7,8 In Dr. Ruit’s technique,
the cataract is removed from the eye
using an irrigating Vectis, as opposed
to the prior Blumenthal technique which
utilized an anterior chamber maintainer
and hydrostatic force to push the lens
out of the eye. Both techniques allow the
surgeon to remove the cataract lens enbloc and without the need to disassemble
the cataract into smaller parts. In contrast,
standard phacoemulsification surgery uses
ultrasonic waves to emulsify and fragment
the lens nucleus, which is then removed
by suction through a small clear corneal
incision.9
While
phacoemulsification
produces excellent results with low
complication rates and minimal induced
astigmatism, MSICS produces similar visual
outcomes with shorter average surgical
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times and at a significantly reduced cost.
Speed and outcomes alone were not
enough to address the burgeoning
cataract rate in third-world countries; an
infrastructure that would allow for highvolume and low-cost cataract surgeries
was needed. In 1994, Dr. Sanduk Ruit and
Dr. Geoffery Tabin created the Himalayan
Cataract Project (HCP) to establish an eye
care infrastructure in Nepal. By 1999, the
team had reduced the cost of MSICS to
less than $20 per surgery and now has
programs in underserved areas of the
world including Nepal, Ghana, Ethiopia,
Bhutan, and India.
A primary reason for the success of HCP
was its unique cost-saving measures.
For example, HCP adopted a crosssubsidization model where wealthy patients
pay a higher fee for the services rendered
to support patients who have severely
limited means.10 One critical factor that
enabled MSICS to become an inexpensive
procedure was the development of lowcost intraocular lenses implanted at the
time of surgery. Key to this was the creation
of the non-profit Aurolab by the Aravind
Eye Hospital in Tamil Nadu, India. Aurolab
reduced manufacturing costs by utilizing a
workforce predominantly of young women
from rural areas who used this internship
as a stepping-stone for further career
opportunities.11 By maximizing India’s
labor cost advantage, Aurolab introduced
its first intraocular lenses (IOLs) at $10
compared to about $105 in the United
States.12 Today, Aurolab produces 19% of
the world’s IOLs and sells them for as low
as $2.13.
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Despite the lower cost and greater
efficiency,
visual
outcomes
from
MSICS do not significantly differ from
phacoemulsification.
A
landmark
prospective randomized control trial by
Ruit et al. compared phacoemulsification
to MSICS and found comparable bestcorrected visual acuities and complication
rates with shorter operative time for MSICS.5
Furthermore, some academic centers have
found a more rapid acclimation to MSICS
than to phacoemulsification in those
surgeons who have previously trained
in ECCE due to the similarities between
procedures.14 Phacoemulsification, on
the other hand, does have its benefits.
It requires a smaller incision than MSICS
(2.2-2.75 mm vs 6-8 mm respectively),
which results in improved intraocular
pressure control, minor to no astigmatism,
and quicker rehabilitation.15 For these
reasons, phacoemulsification continues to
be the gold standard in affluent nations.
Nevertheless, MSICS will still play a role
in treating the most advanced and dense
cataracts in all countries regardless of
their GDP. When phacoemulsification is
used for severely dense cataracts, there is
an increased risk for corneal endothelial
cell loss and iatrogenic corneal edema.16
Future efforts in modernizing MSICS will
focus on minimizing induced astigmatism
while maintaining the endothelial-friendly
aspects of the procedure.
The success of high-volume MSICS centers
throughout the world is a testament to the
individual and combined efforts of the many
surgeons and public health professionals
who have dedicated their lives to treating
avoidable blindness. Several barriers
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remain as gender, socioeconomic status,
poor health literacy, and the perceived cost
of eye care continue to limit patients from
accessing these sight-saving surgeries.3
Women in LMICs are significantly less likely
to undergo cataract surgery than men as
they may have limited financial decisionmaking power or barriers preventing access
to transportation.17 Others may perceive
vision loss as a normal part of aging and
are thus less likely to seek care.3 Future
efforts to combat cataracts worldwide
must not only address accessibility of a
low-cost cataract surgery infrastructure
but also take into account the unique
socioeconomic and cultural milieu of each
region. A multifaceted approach, which
examines the broad spectrum of risk
factors for and barriers to cataract surgery,
will bring us one step closer to eradicating
preventable blindness throughout the
world.
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A Look into Oculoplastics: Repairing Lower
Eyelid Defects From Carcinomas
By Cameron Haghshenas, BS | Faculty Mentor: Robert Penne, MD

E

yelids are the thinnest, most
sensitive skin we have and can easily
be damaged by sun exposure. This
is evident given that 5 - 10% of all skin
cancers occur on the eyelid, and over half
of these occur on the lower eyelid1. Most
of such cases are basal cell carcinomas,
which are slow-growing cancers that arise
from the basal cell layer, the deepest
part of the epidermis. If left untreated
or improperly treated, these tumors can
extend into adjacent tissues and bone, or
recur. Squamous cell carcinomas can also
occur on the lower eyelid, although they
represent only a minority of cases. These
arise from the squamous epithelium,
a layer of scale-like cells found in the
superficial epidermis and they can also
spread and grow into deeper layers of
the skin. Cancers of the lower eyelid are
usually treated with surgical excision and
evaluation of the surgical margins. This
can be done with frozen sections or Mohs
surgery. With frozen sections, the margins
are evaluated by a pathologist at the time
of surgery. Mohs surgery is a procedure
that has been around for decades and is
done by a specialized dermatologist. It
involves excising the carcinoma layer by
layer until it is fully removed. The nonsurgical alternatives are cryotherapy and
radiotherapy.
They are less invasive,
avoid surgery, but have a higher rate of
recurrence compared to surgery2. When
a lot of tissue needs to be removed, the
result is the unilateral loss of a portion of
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Figure 1. Anatomy of eyelid7

the lower eyelid full thickness. This is also
known as a lower eyelid defect, which can
be repaired by an oculoplastic surgeon.
The eyelid consists of the anterior lamella,
which includes the skin and orbicularis
oculi muscle, and a posterior lamella,
which includes the conjunctiva and tarsus
(Figure 1). This anatomy is important to
understand when repairing the lower
eyelid defects.
Oculoplastic surgeons have a host of
procedures available to treat lower eyelid
defects. The choice of procedure depends
on the size of the defect after tumor
excision and patient-specific factors like
eyelid laxity and age.3 For smaller fullthickness defects (Figure 2a) which only
affect around one-fourth of the eyelid
width, one can perform primary closure of
the eyelid margin, which entails apposing
the two free edges to close the gap left
after the tumor excision (Figure 2b). The
goal with primary closure is to do so
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Figure 2a. Small basal cell
carcinoma on lower eyelid

Figure 2b. Excision of small
carcinoma on lower eyelid

with the eyelid margin, tarsus and skin
layers. The eyelid margin is closed first,
the wound edge is everted, and tension
is spread to prevent scarring or notching.
This is followed by suturing the tarsus with
deep sutures and finally closing the skin. A
lateral cantholysis can be done at the time
to allow closure of a larger defect. Upon
healing, patients have a clean, functional
eyelid (Figure 2c)3.
For medium-sized defects, which affect
around one-third to two-thirds of the eyelid
width (Figure 3a), a technique called Tenzel
semicircular flap is performed after cancer
excision (Figure 3b). With this technique,
a semicircular incision beginning from the
lateral canthus, or the lateral edge of the
eyelid, extending upward and laterally
creates a skin-muscle flap. This flap is then
rotated over the excision area. The margin
is closed as with a primary defect and
the rotated flap is closed with deep and

Figure 3a. Medium-sized carcinoma in
lower eyelid

Figure 2c. Lower eyelid after
primary closure

skin sutures (Figure 4)3. This helps avoid
healing defects (Figure 3c).
For larger defects nearing the entirety of
the lower eyelid (Figure 5a), a Hughes flap,
also known as a tarsoconjunctival flap, is
performed after cancer excision (Figure
5b). This flap is created from the tarsus
and conjunctiva of the upper eyelid and
sutured into the gap of the lower eyelid to
create its posterior lamella. The anterior
lamella can come from any remaining skin
on the lower eyelid, or if need be, do a
full-thickness skin graft from the upper
eyelid, retro-auricular or supra-clavicular
areas. It is important to note that due to
this connection, the eyelids are sutured
shut for a period of 4 to 6 weeks (Figure
6). The eyelid margins are then recreated
through a second procedure, resulting in
functional eyelids (Figure 5c)3.
Eyelid lesions like carcinomas can appear

Figure 3b. Excision of mediumsized squamous carcinoma on
lower eyelid

Figure 3c. Lower eyelid after
Tenzel semicircular flap
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Figure 5a. Large carcinoma on lower eyelid
Figure 4. Outline of Tenzel semicircular flap.
The Tenzel flap is marked (A), and a dissection is
performed in plane superior to the orbicularis to
mobilize the flap medially (B). Then, the lid margin is
repaired with flap closure (C)8

even on the smallest parts of our bodies.
The procedures mentioned above are only
a few of the innovative tools oculoplastic
surgeons use to treat and repair lower
eyelids afflicted with such carcinomas. These
procedures have a favorable prognosis,
with the most involved of the procedures,
the Hughes flap, having an 87% success
rate in achieving satisfactory cosmesis and
no further required surgeries.4 The healing
process can take up to 3 months and it
is recommended that the patient checks
up on any reoccurrence of cancer every
6 months.5,6 Through these procedures,
physicians ensure that patients maintain
their health, vision, and facial anatomy.
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Figure 5a. Excision of large basal cell carcinoma on
lower eyelid

Figure 5a. Lower eyelid after Hughes/tarsoconjunctival
flap, prior to reforming the eyelid margins
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Figure 6. Outline of Hughes flap. After excision of the carcinoma (A and B), a flap is created from the tarsus
and conjunctiva of the upper eyelid (C and D) and sutured onto the gap of the lower eyelid, creating its
posterior lamella and eventually anterior lamella (E). The eyelid margins are then recreated (F)9.
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Seeing Eye to Eye: An Overview of
Strabismus and Approach to Treatment
By Shreya Swaminathan, BS | Faculty Mentor: Barry Wasserman, MD

Figure 1. Strabismus correction surgery can be used to correct esotropia (1A, 1B) and exotropia (1C)

S

trabismus is a heterogenous group
of conditions characterized by
the misalignment of the eyes. It
may manifest as constant or intermittent
deviation, meaning the eyes sometimes
appear well aligned, or straight, and
sometimes appear misaligned.
Vision
can be normal in some patients, but
when associated with amblyopia, may
be decreased vision in one eye. There is
sometimes diminished binocular vision,
with decreased depth perception.
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Twin and family studies suggest a
possible genetic component to the
etiology of strabismus.1 Strabismus
most commonly occurs sporadically and
in otherwise healthy patients, but risk
factors that increase the likelihood of
developing strabismus include exposure
to teratogens such as alcohol, retinopathy
of prematurity, premature birth, and
low birthweight.2 Secondary causes of
strabismus include monocular vision loss
from diseases like retinoblastoma or
cataract, neurodevelopmental disorders,
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craniofacial syndromes. Abnormalities and
disorders affecting extra-ocular muscles
and/or their innervation may also affect
ocular alignment.
Strabismus is sometimes described by
the direction of the misaligned eye. In
esotropia, the misaligned eye deviates
medially toward the nose. In exotropia,
the eye deviates laterally toward the ear.
Vertical misalignment is called hypertropia
when the eye drifts or deviates upwards
and hypotropia when the eye deviates
downwards. The strabismus is described
as comitant when it is the same in all gazes,
but incomitant when it changes depending
on the direction the patient is looking.
For example, a patient with a cranial
nerve VI palsy may develop a large angle
esotropia when looking toward the side
of the palsy but may have relatively good
ocular alignment when looking away from
the palsy. This can create variable double
vision, or diplopia, for some patients.
Esotropia, convergent alignment of the
eyes, is more common in children than
exotropia, or divergent alignment of the
eyes.3 Figure 1 depicts adult patients with
esotropia and exotropia before and after
strabismus surgery.
Strabismus can be corrected with
nonsurgical intervention in many cases.
Sometimes correcting the vision with
glasses can achieve excellent ocular
alignment. In some cases, eye exercises,
sometimes referred to as vision therapy
or orthoptics, can help align the eyes. In
cases when nonsurgical interventions are
insufficient, strabismus is often corrected
through surgical intervention. The surgery

is same day and often requires less than
an hour to change a patient’s life. The
goal of strabismus surgery is to effectively
balance the forces of the muscles on the
globe. This modification improves ocular
alignment and in turn, reduces diplopia.
More specifically, strabismus surgery
often involves recession or resection.
Recession changes the position of muscle
attachment to weaken its function. First,
a suture is placed through the muscle at
the attachment site. Next, the muscle is
detached from the scleral surface and
reattached more posteriorly, effectively
‘loosening’ the muscle. Resection, on the
other hand, involves removing a portion
of the muscle and reattaching the muscle
to the original insertion site to effectively
‘tighten’ the muscle.4 Figure 2 highlights
the differences between recession and
resection.
Some strabismus surgeons utilize a
technique called adjustable sutures. In
these procedures, the muscle position is
moved to a desired location, but placed
on a suture with a sliding knot. The patient
can then be tested after surgery, and if
necessary, the position refined with local
anesthesia.
These procedures require
proper patient selection as cooperation
and sometimes additions anesthesia is
required. Whether adjustable or not,
all strabismus surgery carries small risks.
While serious risks like infection and loss of
vision are extremely rare, a small number
of patients do require another surgery
later in life, as the eyes may deviate again.
Treating strabismus not only improves
ocular alignment, but also ameliorates the
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Figure 2. Strabismus muscle involves cutting through the conjunctiva (2A) and tenon’s fascia
(2B) to isolate the lateral rectus muscle, as seen resting on the hook (2C). In a resection, the
amount to be resected is measured using a caliper (2D) and a suture is placed accordingly (2E).
The portion of the muscle located anterior to the suture is resected and the muscle is then
reattached to the globe (2F). This serves to strengthen the ocular muscle. In a recession, the
caliper measures the position where the new insertion of the muscle will be placed (2G). The
initial suture is placed at the insertion (2H) in contrast to the suture placement in a resection.
The lateral rectus muscle is reinserted to the superficial sclera posterior to the original position
of the insertion (2I) to loosen the muscle and weaken its function.
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negative psychosocial impacts associated
with the condition. Many patients,
particularly adults with longstanding
misalignments, are told their strabismus
is ‘just cosmetic.’ Patients with untreated
strabismus report more psychosocial
difficulties that tend to intensify in
adulthood, contrary to popular belief of
dissipation with age. Specifically, strabismus
can impact self-image, sports participation,
school achievement, and interpersonal
relationships. Occasionally, patients report
difficulty securing employment or false
accusations of cheating due to the inability
to make eye contact. For these reasons,
strabismus is not considered cosmetic,
and surgery is covered by insurance.
Strabismus surgery offers the opportunity
to make a substantial difference in patients’
lives and can be extremely rewarding for
both the patient and the surgeon. Future
studies are needed to further quantify the
benefits of strabismus correction from a
psychosocial standpoint.5

References
1. Michaelides
M.
The
genetics
of
strabismus.
J
Med
Genet.
2004;41(9):641-646.
doi:10.1136/
jmg.2004.021667
2. Maconachie GDE, Gottlob I, McLean
RJ. Risk Factors and Genetics in
Common Comitant Strabismus: A
Systematic Review of the Literature.
JAMA Ophthalmol.
3. 2013;131(9):1179-1186. doi:10.1001/
jamaophthalmol.2013.4001
4. Bommireddy T, Taylor K, Clarke MP.
Assessing strabismus in children.
Paediatrics
and
Child
Health.
2019;30(1):14-18.
doi:10.1016/j.
paed.2019.10.003
5. Strabismus
Surgery
American
Association for Pediatric Ophthalmology
and Strabismus. Accessed December
18, 2021. https://aapos.org/glossary/
strabismus-surgery
6. Psychosocial Aspects of Strabismus
Study | JAMA Ophthalmology | JAMA
Network. Accessed December 18, 2021.
https://jamanetwork.com/jour nals/
jamaophthalmology/fullarticle/640327

May 2022 | 41

Thomas Duane
Ophthalmology Society
The Thomas Duane Ophthalmology Society (TDOS) at Sidney Kimmel
Medical College (SKMC) at Thomas Jefferson University is dedicated to
promoting interest in the medical specialty of ophthalmology through
lectures and interactive programming for the Jefferson Community.
We are also committed to volunteerism, and connect SKMC students
with our community partners through ophthalmology-related volunteer
opportunities, including Give Kids Sight Day and vision screenings at
JeffHOPE clinics.
A central goal of TDOS is to support student engagement with educational
opportunities in ophthalmology. Our annual introductory talk, hosted by
Dr. Bruce Markovitz, aims to raise awareness and promote interest in the
field and its subspecialties. With the support of Wills Eye Hospital, we
also host an annual resident-run slit lamp workshop, bi-monthly wet lab
sessions, and organize panel discussions with physicians.
To strengthen the unique connection between Wills Eye Hospital faculty
and Thomas Jefferson students, we have included new additions to the
TDOS programming, including monthly journal clubs. Finally, inSIGHT
has offered students a hands-on opportunity to write about and directly
engage with ophthalmology research and developments under the close
mentorship of a Wills Eye physician.
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